An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution
Claire S. Waddington(University of Oxford), Andrew J. Pollard(University of Oxford), Marcelo B. Sztein(University of Maryland, Baltimore), Thomas C. Darton(Sheffield Teaching Hospitals NHS Foundation Trust), Anna L. Peters(National Institute for Health and Care Research), Robert A. Kingsley(University of East Anglia), Stephen Lockhart(Johns Hopkins University), Ly‐Mee Yu(Dartmouth–Hitchcock Medical Center), Myron M. Levine(University of Maryland, Baltimore), Simon Kerridge(University of Oxford), Tessa M. John(National Institute for Health and Care Research), Jeremy Farrar(World Health Organization), Kathryn E. Holt(London School of Hygiene & Tropical Medicine), Liqing Zhou(National Institute for Health and Care Research), Kathryn Haworth(National Institute for Health and Care Research), Claire Jones(National Institute for Health and Care Research), Ben Thompson(Manchester Royal Infirmary), Gordon Dougan(University of Cambridge), Brian Angus(University of Oxford)
Cited by 155
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
The global distribution and burden of dengue
|Nature|2013|10.1k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k